Periarticular osteopenia in adjuvant induced arthritis: role of interleukin-1 in decreased osteogenic and increased resorptive potential of bone marrow cells
- PMID: 7632091
- PMCID: PMC1009907
- DOI: 10.1136/ard.54.6.484
Periarticular osteopenia in adjuvant induced arthritis: role of interleukin-1 in decreased osteogenic and increased resorptive potential of bone marrow cells
Abstract
Objective: To clarify the local osteogenic and bone resorptive potential of periarticular bone in adjuvant induced arthritis (AIA).
Methods: Formation of fibroblast colony forming units (FCFU; osteogenic precursor cells) and osteoclast-like cells in bone marrow culture was studied in AIA rats. Osteoclast-inducing activity in the AIA rat bone marrow was assayed by the addition of the marrow supernatant from rats with AIA to control cultures. Bone mineral density was determined by dual x ray absorptiometry.
Results: Marrow from AIA rats and that from animals receiving recombinant human interleukin-1 (IL-1) beta for seven days grew significantly fewer FCFU than control marrow. Formation of osteoclast-like cells was increased in bone marrow cultures from rats with AIA, especially when bone marrow cells were cultured in the presence of marrow supernatant. Formation of resorption lacunae on ivory slices was increased in the marrow cultures from rats with AIA, especially from the right (adjuvant inoculated) tibia. AIA rat marrow supernatant promoted osteoclast-like cell formation in control culture, and this was significantly suppressed by an anti-IL-1 antibody. Rats with AIA showed a significant decrease in the bone mineral density of the periarticular regions of the tibia and femur.
Conclusion: An uncoupled state in bone resorption-formation linkage, possibly mediated through an increase of IL-1 in the bone marrow, may contribute to the development of periarticular osteopenia in inflammatory arthritis.
Similar articles
-
Short-term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant induced arthritis.J Rheumatol. 1997 Oct;24(10):1890-5. J Rheumatol. 1997. PMID: 9330928
-
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.Arthritis Res Ther. 2009;11(6):R187. doi: 10.1186/ar2879. Epub 2009 Dec 11. Arthritis Res Ther. 2009. PMID: 20003323 Free PMC article.
-
Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect.J Bone Miner Res. 1993 Jun;8(6):659-68. doi: 10.1002/jbmr.5650080603. J Bone Miner Res. 1993. PMID: 8328307
-
1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption.BMC Musculoskelet Disord. 2014 Oct 14;15:345. doi: 10.1186/1471-2474-15-345. BMC Musculoskelet Disord. 2014. PMID: 25315028 Free PMC article.
-
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.J Bone Miner Res. 2005 Oct;20(10):1756-65. doi: 10.1359/JBMR.050601. Epub 2005 Jun 6. J Bone Miner Res. 2005. PMID: 16160733
Cited by
-
Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models.Rheumatol Int. 2006 May;26(7):627-32. doi: 10.1007/s00296-005-0042-y. Epub 2005 Aug 27. Rheumatol Int. 2006. PMID: 16133581
-
Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.Rheumatol Int. 2009 Oct;29(12):1403-9. doi: 10.1007/s00296-009-0867-x. Epub 2009 Feb 15. Rheumatol Int. 2009. PMID: 19219607
-
Incadronate disodium inhibits joint destruction and periarticular bone loss only in the early phase of rat adjuvant-induced arthritis.J Bone Miner Metab. 2005;23(4):295-301. doi: 10.1007/s00774-004-0602-3. J Bone Miner Metab. 2005. PMID: 15981025
-
Osteoporosis in rheumatoid arthritis.Osteoporos Int. 1997;7 Suppl 3:S217-22. doi: 10.1007/BF03194376. Osteoporos Int. 1997. PMID: 9536336 Review.
-
Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism.Rheumatol Int. 2006 Aug;26(10):908-15. doi: 10.1007/s00296-005-0095-y. Epub 2006 Jan 11. Rheumatol Int. 2006. PMID: 16404562
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources